ArticleNeuro-oncology advances

Targeted next-generation sequencing-based sequencing of cell-free DNA in cerebrospinal fluid uncovers cancer-specific mutations in patients with brain cancer using a widely available panel.

Alexander Köpp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.